Towards third generation matrix metalloproteinase inhibitors for cancer therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6603043.pdf
Reference35 articles.
1. Bertini I, Calderone V, Cosenza M, Fragai M, Lee YM, Luchinat C, Mangani S, Terni B, Turano P (2005) Conformational variability of matrix metalloproteinases: beyond a single 3D structure. Proc Natl Acad Sci USA 102: 5334–5339
2. Bredemeyer AJ, Lewis RM, Malone JP, Davis AE, Gross J, Townsend RR, Ley TJ (2004) A proteomic approach for the discovery of protease substrates. Proc Natl Acad Sci USA 101: 11785–11790
3. Butler G, Overall CM (2006) Proteases as drug targets. Pharmacoproteomics for protease drug target validation of matrix metalloproteinase inhibitor drugs using isotope-coded affinity tags. Curr Pharm Design in press
4. Castelhano AL, Billedeau R, Dewdney N, Donnelly S, Horne S, Kurz LJ, Liak TJ, Martin R, Uppington R, Yuan Z, Krantz A (1995) Novel indolactam-based inhibitors of matrix metalloproteinases. Bioorganic Med Chem Lett 5: 1415–1420
5. Chen JM, Nelson FC, Levin JI, Mobilio D, Moy FJ, Nilakantan R, Zask A, Powers R (2000) Structure-based design of a novel, potent, and selective inhibitor for MMP-13 utilizing NMR spectroscopy and computer-aided molecular design. J Am Chem Soc 122: 9648–9654
Cited by 300 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent discovery of natural substances with cathepsin L-inhibitory activity for cancer metastasis suppression;European Journal of Medicinal Chemistry;2024-11
2. Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer;Frontiers in Oncology;2024-01-15
3. Metalloproteinases as Biomarkers and Sociomarkers in Human Health and Disease;Biomolecules;2024-01-11
4. Discovery of novel indole derivatives as potent and selective inhibitors of proMMP-9 activation;Bioorganic & Medicinal Chemistry Letters;2024-01
5. New Derivatives of N-Hydroxybutanamide: Preparation, MMP Inhibition, Cytotoxicity, and Antitumor Activity;International Journal of Molecular Sciences;2023-11-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3